Literature DB >> 7902707

Exon structure and flanking intronic sequences of the human RET proto-oncogene.

I Ceccherini1, R Bocciardi, Y Luo, B Pasini, R Hofstra, M Takahashi, G Romeo.   

Abstract

Using a PCR strategy based on an initial set of 15 couples of primers designed from the known cDNA sequence, we identified 18 introns in the human RET proto-oncogene and sequenced the corresponding 5' and 3' exon-intron junctions. This approach was successful in locating all the introns contained in fragments short enough to be amplified by PCR. Thus 19 exons were identified which, together with the previously reported exon subjected to alternative splicing, brings the total number of RET exons to 20. This information is relevant for the screening of recently reported missense mutations of RET which cause Multiple Endocrine Neoplasia 2A (MEN2A) and for the search of additional point mutations of the same gene which might cause two other neural crest disorders, MEN2B and Hirschsprung disease, mapping in the same region as MEN2A.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902707     DOI: 10.1006/bbrc.1993.2392

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

Review 3.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 4.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

Review 5.  Hirschsprung's disease as a neurochristopathy.

Authors:  G Martucciello
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

6.  Genotyping analysis of 3 RET polymorphisms demonstrates low somatic mutation rate in Chinese Hirschsprung disease patients.

Authors:  Zhen Zhang; Qian Jiang; Qi Li; Wei Cheng; Guoliang Qiao; Ping Xiao; Liang Gan; Lin Su; Chunyue Miao; Long Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  RET proto-oncogene mutations and rearrangements in endocrine diseases.

Authors:  R V Lloyd
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

8.  The results of molecular genetic testing for RET proto-oncogene mutations in patients with medullary thyroid carcinoma in a referral center after the two decade period.

Authors:  B Rovcanin; S Damjanovic; V Zivaljevic; A Diklic; M Jovanovic; I Paunovic
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

9.  Autonomic dysfunction in children with Hirschsprung's disease.

Authors:  A Staiano; L Santoro; R De Marco; E Miele; F Fiorillo; A Auricchio; M L Carpentieri; J Celli; S Auricchio
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

10.  Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families.

Authors:  M Rossel; I Schuffenecker; M Schlumberger; C Bonnardel; E Modigliani; P Gardet; J Navarro; Y Luo; G Romeo; G Lenoir
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.